Incoming material control
Every active and excipient lot is quarantined, sampled under LAF and tested for identity, assay and impurity profile before it can be dispensed.
RIVANOVA
Quality Assurance
Independent QA authority, ALCOA+ data integrity, and analytical testing on every incoming material, in-process stage and finished batch.
Quality architecture
Quality assurance at RIVANOVA reports to the board, not to production. That single structural decision is what makes the rest credible: a QA officer who rejects a batch is not overruling their own manager, and cannot be pressured by a despatch deadline.
The function covers incoming material testing, in-process control, finished goods release, stability monitoring, deviation and CAPA management, change control, self-inspection and supplier qualification. It holds the retention samples, it owns the audit trails, and it signs — or withholds — every release.
Batch-release conformance against specification, rolling 36 months.
Product recalls initiated in the company's operating history.
Regulatory and customer audits hosted in the last three years.
Incoming actives re-tested in-house regardless of supplier certificate.
Analytical laboratory — Quality Control
HPLC · GC · UV-Vis · FTIR · dissolution · stability chambers
Quality systems
Every active and excipient lot is quarantined, sampled under LAF and tested for identity, assay and impurity profile before it can be dispensed.
Weight variation, hardness, friability, disintegration, fill volume and pH are monitored throughout the run, with automatic rejection where limits are breached.
Real-time and accelerated studies under ICH Zone II and IVb conditions, with photostability per Q1B. Every commercial product carries an ongoing stability commitment.
Every deviation is logged, investigated to root cause and closed with corrective and preventive actions whose effectiveness is verified before closure.
No change to a process, specification, supplier or facility proceeds without documented impact assessment and QA approval — including changes that look trivial.
A cross-functional team audits every department annually against GMP requirements, with findings tracked to closure exactly like a regulatory observation.
Most data integrity findings are not fraud. They are a system that made the honest path harder than the convenient one. We design for the opposite.
Dr. A. Nambiar
Head — Quality Assurance
Data integrity
Data integrity is not a training topic here — it is a set of technical controls that make non-compliant behaviour impossible rather than merely prohibited.
Analytical scope
| Test | Applies to | Instrumentation | Reference standard |
|---|---|---|---|
| Assay & related substances | All dosage forms | HPLC with UV / PDA detection | IP · BP · USP monograph |
| Dissolution profile | Tablets, capsules | USP Apparatus I & II | USP <711> |
| Uniformity of dosage units | Tablets, capsules, vials | HPLC · analytical balance | USP <905> |
| Residual solvents | Oral solids, injectables | Headspace GC-FID | ICH Q3C |
| Identification | All raw materials | FTIR · UV-Vis | Pharmacopoeial reference spectra |
| Microbial limits | Oral liquids, topicals, nutrition | Microbiology suite | USP <61> / <62> |
| Sterility & endotoxin | Injectables | Isolator · LAL assay | USP <71> / <85> |
| Water content | Hygroscopic solids, powders | Karl Fischer titration | USP <921> |
| Particulate matter | Injectables | Light obscuration counter | USP <788> |
| Purified water & WFI | Utility systems | TOC · conductivity · bioburden | USP <643> / <645> |
Certificates of Analysis, validation reports, stability data and site master files are available to qualified partners on request.